Cell Lines Available for Research

Nine cell lines are available to commercial and academic researchers worldwide who are seeking a cure for lymphoma, leukemia, pancreatic cancer, or macroglobulinema.

The cell lines were developed by researchers at the Barbara Ann Karmanos Cancer Institute of Wayne State University (Detroit, MI, USA) and are being distributed by Asterand, Inc. (Detroit, MI, USA; www.asterand.com). Asterand also markets breast cancer cell lines under license from the University of Michigan (Ann Arbor, USA) and prostate cancer lines from Onyvax (London, UK). The company acquires donated samples from a world-wide network of collaborating hospitals and clinics.

Following are the cell lines available: Waldenstrom's macroglobulinema, follicular small cleaved cell lymphoma, diffuse large cell lymphoma (chemo-resistant), acute lymphoblastic leukemia (early stage), acute myeloid leukemia, pancreatic cancer, diffuse large cell lymphoma, Burkitt's lymphoma, and nodal histiocytic lymphoma (intermediate grade).

"These cell lines are very good model systems for diseases they are derived from,” said Dr. James Eliason, chief scientific officer of Asterand. "They have been studied extensively by researchers at Wayne State University and elsewhere, which is evident by the fact that there are over 50 publications related to them. In addition to common cancers, these cell lines are great resources for studying rare cancers such as Burkitt's lymphoma, which affects children and young people, aged 12-30, or pancreatic cancer, which is probably one of the most difficult cancers to detect.”




Related Links:
Asterand